Ariana Shemms, in Las Vegas, NV - Occupational Therapist

Ariana Shemms, is a Occupational Therapist - Pediatrics based in Las Vegas, Nevada. Ariana Shemms is licensed to practice in * (Not Available) (license number ) and her current practice location is 2012 S Jones Blvd, Las Vegas, Nevada. She can be reached at her office (for appointments etc.) via phone at (702) 360-1137.

NPI number for Ariana Shemms is 1134614803 and her current mailing address is 3395 S Jones Blvd # 363, Las Vegas, Nevada. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1134614803.

Contact Information

	Ariana Shemms,
	2012 S Jones Blvd, Las Vegas, NV 89146-3151
	(702) 360-1137
	Not Available

Healthcare Provider's Profile

Full Name	Ariana Shemms
Gender	Female
Speciality	Occupational Therapist - Pediatrics
Location	2012 S Jones Blvd, Las Vegas, Nevada
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1134614803
Provider Enumeration Date: 06/26/2018
Last Update Date: 06/26/2018

Medical Identifiers

Medical identifiers for Ariana Shemms such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1134614803	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225XP0200X	Occupational Therapist - Pediatrics	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ariana Shemms is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ariana Shemms, 3395 S Jones Blvd # 363, Las Vegas, NV 89146-6729 Ph: () -	Ariana Shemms, 2012 S Jones Blvd, Las Vegas, NV 89146-3151 Ph: (702) 360-1137

News Archive

Second worker tested for bird flu on British farm

The Health Protection Agency (HPA) in the UK has announced that the vet who became ill after working on the farm where an outbreak of bird flu has occurred, has tested negative for the virus.

EC grants orphan drug designation to S*BIO's SB1518 for treatment of myelofibrosis

S*BIO Pte Ltd today announced that the European Commission (EC) has granted orphan drug designation to SB1518, its potent and orally active JAK2 inhibitor for the treatment of primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) and post-essential thrombocythemia myelofibrosis (PET-MF). SB1518 has also received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of the same disorder.

Scientists analyze new technique to quickly identify particular asthma subtypes

For many people afflicted by asthma, treatment can be a frustrating and time-consuming experience. After their initial diagnosis, asthmatics find themselves caught in a trial and error process that can last for months, as doctors gradually escalate their medications to treat their condition effectively with minimal side effects. And until the right medicine and dosage are found, patients continue to suffer attacks that strike without warning and can leave them struggling for breath for hours or even days.

Non-small cell lung cancer patients who undergo PCI decrease their risk of developing brain metastases

Patients with non-small cell lung cancer treated with preventative brain radiation (called prophylactic cranial irradiation or PCI), significantly decrease their risk of developing brain metastases (cancer spread in the brain) by more than 50 percent (from 18 percent to 8 percent), compared to those who did not receive the treatment, according to a randomized study presented at the plenary session November 2, 2009, at the 51st Annual Meeting of American Society for Radiation Oncology (ASTRO).

Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer

Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).

Occupational Therapist in Las Vegas, NV

Miss Sheila Acosta Marquez, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4275 Burnham Ave, Ste. 225 Desert Springs Therapy Clinic, Las Vegas, NV 89119 Phone: 702-380-1060 Fax: 702-380-1081
Farah Michelle Westreich, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8000 Spring Mountain Rd, 2116, Las Vegas, NV 89117 Phone: 954-253-3739
Alicia Marie Schwarz, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1525 E Windmill Ln, #202, Las Vegas, NV 89123 Phone: 702-434-6920 Fax: 702-361-8596
Geoffrey Shih, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 6161 W Charleston Blvd, Las Vegas, NV 89146 Phone: 702-468-8311
Mrs. Kelly Jean Squire-hamblet, MSOTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 5540 Azuza Ave, Las Vegas, NV 89122 Phone: 702-348-9076
Autism & Behavioral Consulting Services Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7560 W Sahara Ave Ste 107, Las Vegas, NV 89117 Phone: 702-476-2633 Fax: 702-979-1028
Mrs. Jennifer C Travers, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3030 S Jones Blvd, Suite 105, Las Vegas, NV 89146 Phone: 702-360-1137 Fax: 702-341-1511

Ariana Shemms, - Occupational Therapist in Las Vegas, NV